Literature DB >> 4561079

Non-specific resistance induced by palmitoylethanolamide.

H Rasková, K Masek, O Linèt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4561079     DOI: 10.1016/0041-0101(72)90174-2

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


× No keyword cloud information.
  6 in total

1.  Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections.

Authors:  K Masek; F Perlík; J Klíma; R Kahlich
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

2.  Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2014-05-27       Impact factor: 4.473

Review 3.  Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives.

Authors:  Rutger Kriek
Journal:  Inflammopharmacology       Date:  2014-03-20       Impact factor: 4.473

4.  Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.

Authors:  Sandra Redlich; Sandra Ribes; Sandra Schütze; Roland Nau
Journal:  J Neuroinflammation       Date:  2014-06-14       Impact factor: 8.322

Review 5.  Fundamentals of and Critical Issues in Lipid Autacoid Medicine: A Review.

Authors:  Jan M Keppel Hesselink
Journal:  Pain Ther       Date:  2017-06-19

6.  Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical.

Authors:  Jan M Keppel Hesselink
Journal:  J Pain Res       Date:  2013-08-08       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.